(Q42623087)

English

Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study

scientific article published on February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study (English)

1 reference

Europe PubMed Central

3 November 2017

0 references

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

Gabriel Herrero-Beaumont

2

1 reference

Europe PubMed Central

3 November 2017

author name string

Carmen Turbí

1

1 reference

Europe PubMed Central

3 November 2017

Juan Carlos Acebes

3

1 reference

Europe PubMed Central

3 November 2017

Antonio Torrijos

4

1 reference

Europe PubMed Central

3 November 2017

Jenaro Graña

5

1 reference

Europe PubMed Central

3 November 2017

Roberto Miguélez

6

1 reference

Europe PubMed Central

3 November 2017

JoséAntonio Sacristán

7

1 reference

Europe PubMed Central

3 November 2017

Fernando Marín

8

1 reference

Europe PubMed Central

3 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2004

1 reference

Europe PubMed Central

3 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

3 November 2017

26

1 reference

Europe PubMed Central

3 November 2017

2

1 reference

Europe PubMed Central

3 November 2017

245-256

1 reference

Europe PubMed Central

3 November 2017

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early discontinuation of treatment for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of medication compliance in uncontrolled hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with treatment regimens in chronic asymptomatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring the impact of patient counseling in the outpatient pharmacy setting: the research design of the Kaiser Permanente/USC patient consultation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient compliance and medical research: issues in methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Compliance with tricyclic antidepressants: the value of four different methods of assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Congruence of three self-report measures of medication adherence among HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of gastrointestinal side effects due to alendronate is high in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability and compliance with risedronate in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990023-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90023-9

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42623087&oldid=1963311371"